Location: Madrid/Barcelona, Spain (Hybrid / Flexible)
Why this role
Spanish pharmaceutical marketing still runs largely on people power: more representatives, more visits, more headcount pushed at the same doctors – only more complicated. You will change that. This role puts you in front of the senior marketers who set brand strategy in Spain and asks you to rebuild how they reach physicians — using technology, data and M3’s HCP platforms instead of sheer field effort. M3 affiliates have developed a more complex and integrated service portfolio which required and in depth market knowlegde together with a developed commercial sese It is a rare combination: consulting-grade problem solving, a national market as your canvas, and a direct line to the Managing Directors who own the P&L.
The mission
Advance pharmaceutical marketing in Spain from labour-intensive, headcount-driven field tactics to modern, technology- and data-led engagement — and build the commercial engine that makes that shift pay.
You will operate at the intersection of consultative client strategy, product growth and new business development. You will diagnose what pharma brand teams are really trying to solve, design the digital answer, sell it, and then help build the services that do not exist yet. Autonomy is high and the work is visible: what you win shows up directly in the revenue of M3’s Spanish businesses.
What you will do
What you will bring
Preferred
Why join
Hybrid position based in Madrid or Barcelona
About M3 EU:
M3 EU is at the forefront of healthcare innovation, offering digital solutions across healthcare, life sciences, pharmaceuticals, and more. Since our inception in 2000, we’ve seen remarkable growth, fuelled by our mission to utilize the internet for a healthier world and more efficient healthcare systems.
Our success is anchored in our trusted digital platforms that engage physician communities globally, facilitating impactful medical education, precise job placement, and insightful market research. M3 EU prides itself on a dynamic and innovative work environment where every team member contributes to global health advancements.
Joining M3 EU means being part of a dedicated team striving to make a significant difference in healthcare. We provide a unique opportunity for you to be at the cutting edge of healthcare innovation, shaping the future in a meaningful career. Embrace the chance to drive change with M3 EU.
#LI-JG1
#LI-Hybrid
Job details are sourced from the employer's original posting.
Open job postingAbout the company
About m360 Research (m360 Research is a wholly owned subsidiary of M3) : m360 Research is a full-service market research agency specializing in the healthcare space. Our proprietary panels include over 1 million physicians across 75 specialties in addition to substantial communities of allied HCPs, and payers. Founded in 2004, with a strong provenance in technology and innovation, m360 is committed to high quality and actionable insights, underpinned by robust physician verification and ISO certification (9001, 20252, 27001). International fieldwork services are complemented by full service advanced analytics to power data-driven decision making. About M3: A Japanese global leader in the provision of ground-breaking and innovative technological and research solutions to the healthcare industry. The M3 Group operates in the US, Asia, and Europe with over 5.8 million physician members globally via its physician websites which include mdlinx.com, m3.com, research.m3.com, Doctors.net.uk, medigate.net, and medlive.cn. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413, NIKKEI 225) with subsidiaries in major markets including the US, UK, Japan, South Korea, and China, and in 2020 was ranked in Forbes’ Global 2000 list. The M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Japan, UK, France, Germany, Brazil, Sweden, China, USA, and South Korea, as well as India.